Advertisement

Ads Placeholder
Loading...

Lyka Labs Limited

LYKALABS.NS•NSE
Healthcare
Biotechnology
₹55.53
₹4.36(8.52%)
Indian Market opens in 30h 33m

Lyka Labs Limited (LYKALABS.NS) Stock Overview

Explore Lyka Labs Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap2B
P/E Ratio-303.27
EPS (TTM)$-0.17
ROE-0.01%
Fundamental Analysis

AI Price Forecasts

1 Month$56.80
3 Months$21.86
1 Year Target$120.36

LYKALABS.NS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Lyka Labs Limited (LYKALABS.NS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 48.77, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $120.36.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -303.27 and a market capitalization of 2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
8.52%
5-Day Change
7.10%
1-Month Change
-8.62%
3-Month Change
-32.60%
6-Month Change
-43.10%
Year-to-Date (YTD) Change
-27.50%
1-Year Change
-48.08%
3-Year Change
-48.15%
5-Year Change
93.15%
All-Time (Max) Change
170.88%

Contact Information

https://www.lykalabs.com
91 22 6611 2200
Spencer Building, Mumbai, NaN, 400036

Company Facts

4,230 Employees
IPO DateJan 1, 1996
CountryIN
Actively Trading

Frequently Asked Questions